B-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) [Phase 1]
Phase 1 study update for CD19 CAR-allogeneic NKT therapy (ANCHOR) in relapsed or refractory B-cell malignancies; the trial is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of magrolimab in combination with rituximab (with or without chemotherapy) in relapsed/refractory B-cell non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1) [Phase 1]
This update reports Phase 1 safety findings for MB-CART2019.1 in patients with B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma [Phase 1]
This update notes the completion of a Phase 1 study evaluating C-CAR039 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL) [Phase 1]
Phase 1 study assessing feasibility and safety of UCD19 CD19-directed CAR T cells in adults with relapsed/refractory B-cell non-Hodgkin lymp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia [NA]
A clinical trial update indicates that JY231 injections are being studied for relapsed/refractory B-cell acute lymphoblastic leukemia and B-…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma [Phase 1]
Phase 1 clinical trial evaluating pentostatin, bendamustine, and ofatumumab for chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma [Phase 1]
Phase 1 study of PCLX-001 in relapsed/refractory advanced solid tumors and B-cell non-Hodgkin lymphoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas [Phase 1, Phase 2]
Clinical trial update on a Phase I/II study evaluating the safety of autologous CD20 CAR-T cells in relapsed or refractory B-cell non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of HMPL-760 in relapsed/refractory B-cell non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial of LUCAR-20SP in relapsed or refractory B-cell non-Hodgkin lymphoma is currently recruiting at a Chinese cancer cen…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of a conditioning regimen using gemcitabine hydrochloride, clofarabine, and b…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 study of C752 in patients with refractory/relapsed B-cell non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of pembrolizumab with TGR-1202 (umbralisib) in relapsed/refractory chronic lymph…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase Ib/II trial evaluating mosunetuzumab in combination with CHOP or CHP-Polatuzumab Vedotin in B-cell non-Hodgkin lymphoma; the study has…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas [Phase 1]
Phase 1 trial evaluating SD-101 (TLR9 agonist) and BMS-986178 (anti-OX40 antibody) with radiation therapy for low-grade B-cell non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement [Phase 2]
Phase 2 study evaluating high-dose sequential chemoimmunotherapy for B-cell lymphomas with central nervous system involvement has completed …
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies [Phase 2]
This Phase 2 trial studied the combination of lenalidomide and ipilimumab after stem cell transplantation in patients with hematologic or ly…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: MB-CART20.1 Lymphoma [Phase 1, Phase 2]
Miltenyi Biomedicine's MB-CART20.1 Lymphoma trial in relapsed or refractory B-cell non-Hodgkin lymphoma and non-Hodgkin lymphoma has complet…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma [EARLY_Phase 1]
An early Phase 1 clinical study is evaluating the safety and preliminary efficacy of AcNK-Sup003 cell injections for relapsed or refractory …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies [Phase 1]
Phase 1 study of CAR20.19.22 T-cells in relapsed/refractory B-cell malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 study evaluating RO7443904 in combination with glofitamab for relapsed/refractory B-cell non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase I dose-escalation study of oral S-55746 in patients with chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial of Capivasertib in relapsed or refractory B-cell non-Hodgkin lymphoma has completed, with results posted in June 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL [Phase 2]
Phase 2 study evaluating Debio 1562 in combination with Rituximab for relapsed/refractory Diffuse Large B-Cell Lymphoma and other B-cell non…